Log In
BCIQ
Print this Print this
 

NPH29

  Manage Alerts
Collapse Summary General Information
Company nPharmakon LLC
DescriptionCyclooxygenases (COX), stem cell factor (SCF) receptor tyrosine kinase (c-Kit; KIT; CD117) and 5-lipoxygenase (ALOX5; 5-LO) inhibitor
Molecular Target Cyclooxygenases (COX) ; Stem cell factor (SCF) receptor tyrosine kinase (c-Kit) (KIT) (CD117)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard Indication Dermatology (unspecified)
Indication DetailsTreat skin hyperpigmentation
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today